Home | Welcome to Contract Pharma   
Last Updated Thursday, October 30 2014
Print

Breaking News

Related Searches: contractpharma.com cGMP Phase I Packaging
Kristin Brooks
January 9, 2014
To develop therapeutics for hemoglobinopathies  Read More »
Kristin Brooks
January 9, 2014
Platform provides successful scale up of protein for Phase I trial  Read More »
Kristin Brooks
January 9, 2014
To manufacture biologics for Index portfolio companies  Read More »
Kristin Brooks
January 9, 2014
Kollidon polymers meet cGMP requirements  Read More »
Kristin Brooks
January 9, 2014
Mitchell brings 25 years of finance experience  Read More »
Gil Roth
January 9, 2014
Acasti, AZ, BMS, Celator, DiaMedica, GSK, Intercept, Senesco, Vertex  Read More »
Kristin Brooks
January 8, 2014
Gains therapeutic franchises in $2.9 billion buyout  Read More »
Kristin Brooks
January 8, 2014
Supports more than 300 successful NDAs  Read More »
Kristin Brooks
January 8, 2014
Will utilize ImmTAC technology to develop cancer therapies  Read More »
Kristin Brooks
January 8, 2014
Olds brings scientific, operational, and financial experience  Read More »
Kristin Brooks
January 8, 2014
To evaluate the potential of SINE compounds in inflammatory disease  Read More »
Kristin Brooks
January 8, 2014
Phase III programs advance  Read More »
Kristin Brooks
January 8, 2014
AbbVie gains additional rights to Seattle Genetics technology  Read More »
Kristin Brooks
January 8, 2014
Singh brings 25 years of experience  Read More »
Gil Roth
January 8, 2014
No observations at Manchester, NH site following GMP/PAI visit  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On